Tada, R., Suzuki, H., Ogasawara, M., Yamanaka, D., Adachi, Y., Kunisawa, J., & Negishi, Y. (2021). Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation against Streptococcus pneumoniae Infections in Mice. Pharmaceutics.
Chicago Style CitationTada, Rui, Hidehiko Suzuki, Miki Ogasawara, Daisuke Yamanaka, Yoshiyuki Adachi, Jun Kunisawa, i Yoichi Negishi. "Polymeric Caffeic Acid Acts As a Nasal Vaccine Formulation against Streptococcus Pneumoniae Infections in Mice." Pharmaceutics 2021.
Cita MLATada, Rui, et al. "Polymeric Caffeic Acid Acts As a Nasal Vaccine Formulation against Streptococcus Pneumoniae Infections in Mice." Pharmaceutics 2021.
Atenció: Aquestes cites poden no estar 100% correctes.